Skip to main content
Log in

Association between depression and survival in Chinese amyotrophic lateral sclerosis patients

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

To determine the prevalence of depression, to identify correlated factors for depression, and to explore the impact on the progression or survival of amyotrophic lateral sclerosis (ALS) by depression in a Chinese population. A total of 166 ALS patients were recruited. Diagnosis of depression disorders and the severity of depression were established by using the fourth diagnostic and statistical manual of mental disorders, Hamilton Depression Rating Scale-24 items (HDRS-24) and Beck Depression Inventory (BDI). Major depression was found in 15 patients (9.6 %). The multiple regression analysis showed that a lower ALS Functional Rating Scale-Revised (ALSFRS-R) score was correlated with increasing HDRS scores and BDI scores (P = 0.018 and P = 0.012). No significant difference in the median survival time between ALS patients with and without depression was revealed by Kaplan–Meier analysis (log-rank P = 0.282). Cox hazard model showed that the presence of depression in ALS was unrelated to the survival, while the severity of depression in ALS was correlated with the survival. The presence and severity of depression in ALS did not correlate with the progression of ALS. Major depression in ALS is uncommon. Depression evaluation should be given to ALS patients, especially those with lower ALSFRS-R score. The severity of depression may be associated with the survival; however, depression does not worse the progression of ALS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Strong MJ (2001) Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 28(4):283–298

    Article  CAS  PubMed  Google Scholar 

  2. Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344(22):1688–1700

    Article  CAS  PubMed  Google Scholar 

  3. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V (1996) Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 347(9013):1425–1431

    Article  CAS  PubMed  Google Scholar 

  4. Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6(11):994–1003

    Article  CAS  PubMed  Google Scholar 

  5. Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M (2011) Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 12(2):109–112

    Article  PubMed  PubMed Central  Google Scholar 

  6. Oh H, Sin MK, Schepp KG, Choi-Kwon S (2012) Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabil Nurs 37(3):136–144

    Article  PubMed  Google Scholar 

  7. Olsson Ozanne AG, Strang S, Persson LI (2011) Quality of life, anxiety and depression in ALS patients and their next of kin. J Clin Nurs 20(1–2):283–291

    Article  PubMed  Google Scholar 

  8. Rabkin JG, Albert SM, Del Bene ML, O’Sullivan I, Tider T, Rowland LP, Mitsumoto H (2005) Prevalence of depressive disorders and change over time in late-stage ALS. Neurology 65(1):62–67

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ (2015) Depression and disease progression in amyotrophic lateral sclerosis: a comprehensive meta-regression analysis. J Health Psychol 20(8):1107–1128

    Article  PubMed  Google Scholar 

  10. McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H (2009) Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 80(10):1146–1149

    Article  CAS  PubMed  Google Scholar 

  11. Bocker FM, Seibold I, Neundorfer B (1990) Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 58(6):224–236

    Article  CAS  PubMed  Google Scholar 

  12. Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I (2011) Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler 12(4):297–302

    Article  PubMed  Google Scholar 

  13. Trail M, Nelson ND, Van JN, Appel SH, Lai EC (2003) A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci 209(1–2):79–85

    Article  PubMed  Google Scholar 

  14. Hillemacher T, Grassel E, Tigges S, Bleich S, Neundorfer B, Kornhuber J, Hecht MJ (2004) Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 5(4):245–249

    Article  PubMed  Google Scholar 

  15. Körner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S (2015) Interaction of physical function, quality of life and depression in amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol 15:84

    Article  PubMed  PubMed Central  Google Scholar 

  16. Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H (2011) Depression and QOL in patients with ALS: how do self-ratings and ratings by relatives differ? Qual Life Res 20(4):569–574

    Article  PubMed  Google Scholar 

  17. Lule D, Hacker S, Ludolph A, Birbaumer N, Kubler A (2008) Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int 105(23):397–403

    PubMed  PubMed Central  Google Scholar 

  18. Rabkin JG, Wagner GJ, Del Bene M (2000) Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med 62(2):271–279

    Article  CAS  PubMed  Google Scholar 

  19. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA (1994) Survival in amyotrophic lateral sclerosis. The role of psychological factors, Arch Neurol 51(1):17–23

    Article  CAS  PubMed  Google Scholar 

  20. Zimmerman M, McGlinchey JB, Young D, Chelminski I (2006) Diagnosing major depressive disorder I: a psychometric evaluation of the DSM-IV symptom criteria. J Nerv Ment Dis 194(3):158–163

    Article  PubMed  Google Scholar 

  21. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation Neurology Res G (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Other Motor Neuron Dis 1(5):293–299

    Article  CAS  Google Scholar 

  22. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169(1–2):13–21

    Article  CAS  PubMed  Google Scholar 

  23. Group GLAS (2003) A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology 61(11):1503–1507

    Article  Google Scholar 

  24. Moberg PJ, Lazarus LW, Mesholam RI, Bilker W, Chuy IL, Neyman I, Markvart V (2001) Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 9(1):35–40

    Article  CAS  PubMed  Google Scholar 

  25. Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34(3):1184–1186

    Article  CAS  PubMed  Google Scholar 

  26. Swinscow TD (1976) Statistics at square one: XVIII-Correlation. Br Med J 2(6037):680–681

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ganzini L, Johnston WS, Hoffman WF (1999) Correlates of suffering in amyotrophic lateral sclerosis. Neurology 52(7):1434–1440

    Article  CAS  PubMed  Google Scholar 

  28. Kurt A, Nijboer F, Matuz T, Kubler A (2007) Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 21(4):279–291

    Article  PubMed  Google Scholar 

  29. Narrow WE, Rae DS, Robins LN, Regier DA (2002) Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys’ estimates. Arch Gen Psychiatry 59(2):115–123

    Article  PubMed  Google Scholar 

  30. Feinstein A, Feinstein K (2001) Depression associated with multiple sclerosis’. Looking beyond diagnosis to symptom expression. J Affect Disord 66(2–3):193–198

    Article  CAS  PubMed  Google Scholar 

  31. Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, Rigatelli M (2005) Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 26(4):255–262

    Article  CAS  PubMed  Google Scholar 

  32. Frick E, Tyroller M, Panzer M (2007) Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl) 16(2):130–136

    Article  CAS  Google Scholar 

  33. Averill AJ, Kasarskis EJ, Segerstrom SC (2007) Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 8(4):243–254

    Article  PubMed  Google Scholar 

  34. McLeod JE, Clarke DM (2007) A review of psychosocial aspects of motor neurone disease. J Neurol Sci 258(1–2):4–10

    Article  PubMed  Google Scholar 

  35. Caga J, Ramsey E, Hogden A, Mioshi E, Kiernan MC (2015) A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Support Care 13(4):1019–1024

    Article  PubMed  Google Scholar 

  36. Pisa FE, Logroscino G, Casetta A, Cecotti L, Verriello L, Bratina A, Sartori A, Lazzarino de Lorenzo L, Eleopra R, Barbone R (2015) The Use of Antidepressant Medication before and after the Diagnosis of Amyotrophic Lateral Sclerosis: a population-based cohort study. Neuroepidemiology 44(2):91–98

    Article  PubMed  Google Scholar 

  37. Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S (2013) Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol 20(4):647–654

    Article  CAS  PubMed  Google Scholar 

  38. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC (2009) Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15):1218–1226

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol 19(3):360–375

    Article  PubMed  Google Scholar 

  40. Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotrophic Lateral Scler Frontotemporal Degen 15(1–2):9–14

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank the patients for their participation in the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huifang Shang.

Ethics declarations

Conflict of interest

The authors declared no conflict of interests.

Additional information

Q. Wei and Z. Zheng contribute to this work equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wei, Q., Zheng, Z., Guo, X. et al. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients. Neurol Sci 37, 557–563 (2016). https://doi.org/10.1007/s10072-015-2472-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2472-y

Keywords

Navigation